Cartesian Therapeutics, Inc.
RNAC
$6.49
-$0.17-2.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -802.92% | -48.46% | 14.82% | 68.83% | 94.23% |
| Total Depreciation and Amortization | 25.10% | 111.89% | 200.51% | 531.69% | 78.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,919.18% | 62.71% | -1,002.44% | -98.88% | -102.58% |
| Change in Net Operating Assets | -100.04% | -97.95% | 95.30% | -11.19% | 275.12% |
| Cash from Operations | -152.96% | -213.94% | -21.29% | -45.18% | 69.93% |
| Capital Expenditure | 30.21% | 79.16% | -63.52% | -78.57% | -1,001.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -38.98% | 79.16% | -63.52% | -78.57% | -105.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.11% | -100.00% | -29.17% | -93.96% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -54.55% | -- | -- | -- | 98.93% |
| Cash from Financing | -106.64% | -100.03% | -50.00% | -118.65% | -94.44% |
| Foreign Exchange rate Adjustments | 173.33% | 33.33% | -14.29% | 740.00% | -193.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -176.94% | -112.84% | -26.07% | -221.39% | -144.73% |